Quarterly Financial Results, Study Results, and Appointments - Research Reports on Covidien, Community Health, Express Scripts, Caterpillar and Boeing

NEW YORK, November 7, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Covidien plc (NYSE: COV), Community Health Systems, Inc. (NYSE: CYH), Express Scripts Holding Company (NASDAQ: ESRX), Caterpillar Inc. (NYSE: CAT) and The Boeing Company (NYSE: BA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7772-100free.

--
Covidien plc Research Reports
On November 4, 2014, Covidien plc (Covidien) announced 12-month results of the DEFINITIVE AR study, the first randomized study designed to identify the clinical benefits of plaque removal using directional atherectomy followed by drug coated balloon. According to the Company, the study results demonstrated higher technical success and lower incidence of vessel injuries known as flow-limiting dissections. Additionally, the study suggested that the combination of directional atherectomy and anti-restenosis therapy with drug coated balloons (known as DAART) improves patency in long and severely calcified lesions. "The results suggest DAART may address an unmet clinical need in difficult to treat long or severely calcified lesions," said Professor Thomas Zeller of the Universitaets-Herzzentrum, Bad Krozingen, Germany. The full research reports on Covidien are available to download free of charge at:

http://www.analystsreview.com/Nov-07-2014/COV/report.pdf

--
Community Health Systems, Inc. Research Reports
On November 3, 2014, Community Health Systems, Inc. (Community Health Systems) announced its Q3 2014 financial results. The Company's net operating revenues for the quarter increased 51.1% YoY to $4.8 billion. Community Health Systems' net income attributable to shareholders also jumped to $62 million, or $0.54 per diluted share, from $4 million, or $0.04 per diluted share, in the year ago period. Excluding adjustments, the Company's net income stood at $1.01 per share, beating the average estimate of $0.76 per share in a Reuters' poll of analysts. Community Health Systems said that its Q3 2014 operating results reflect a 49.0% increase in total admissions, and a 53.2% increase in total adjusted admissions compared with the same period in 2013. In a separate same day press release, the Company also announced that its subsidiary has acquired operational control of Gaffney Medical Center, which is a 125-bed hospital located in Gaffney, South Carolina. The full research reports on Community Health are available to download free of charge at:

http://www.analystsreview.com/Nov-07-2014/CYH/report.pdf

--
Express Scripts Holding Company Research Reports
On October 28, 2014, Express Scripts Holding Company (Express Scripts) announced its Q3 2014 financial results. Express Scripts said that its revenue during the quarter fell 0.5% YoY to $25.8 billion. However, the Company's revenue managed to beat the sixteen Wall Street analysts' consensus revenue estimate of $24.93 billion. Net income attributable to the Company increased to $582.3 million, or $0.78 per diluted share, from $426.7 million, or $0.52 per diluted share, in the year ago period. On an adjusted basis, the Company said that it earned $1.29 per share in Q3 2014, which was in-line with average estimates in a Reuters' analysts' poll. Looking ahead, Express Scripts has narrowed its adjusted diluted EPS guidance from a range of $4.84 to $4.92 to a range of $4.86 to $4.90, which maintains the mid-point of $4.88. The full research reports on Express Scripts are available to download free of charge at:

http://www.analystsreview.com/Nov-07-2014/ESRX/report.pdf

--
Caterpillar Inc. Research Reports
On October 23, 2014, Caterpillar Inc. (Caterpillar) announced its Q3 2014 financial results. Caterpillar's consolidated sales and revenue during the quarter increased 0.9% YoY to $13.5 billion, helped by favorable changes in price realizations and currency and increased Financial Products' revenues which counterbalanced the lower sales volume. Hit by the weak demand for mining equipment, Caterpillar's sales volume fell $187 million during the quarter. The Company's net profit for the period increased to $1.0 billion, or $1.63 per diluted share, from $946 million, or $1.45 per diluted share, in the year ago period. Analysts, on average, expected the Company to earn $1.36 a share on sales of $13.2 billion. The company now expects 2014 sales and revenues to be about $55 billion, the middle of the previous outlook range of $54 to $56 billion. The full research reports on Caterpillar are available to download free of charge at:

http://www.analystsreview.com/Nov-07-2014/CAT/report.pdf

--
The Boeing Company Research Reports
On November 4, 2014, The Boeing Company (Boeing) announced the appointment of Gordon Johndroe as Vice President, Government Operations Communications, effective November 7, 2014. Johndroe joins Boeing from Lockheed Martin, where he led worldwide corporate media relations. In his new role, he will be responsible for developing and implementing communications strategies associated with advocacy for the Company's products and businesses, as well as issues management and outreach to the Washington, D.C. news media and related constituencies. The full research reports on Boeing are available to download free of charge at:

http://www.analystsreview.com/Nov-07-2014/BA/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review